Insiders · BCRX

Anthony Doyle

Chief Financial Officer at Biocryst Pharmaceuticals Inc (BCRX)

Anthony Doyle has filed 10 insider reports with the SEC since November 2021, as chief Financial Officer at Biocryst Pharmaceuticals Inc (BCRX). Anthony Doyle made no open-market purchases or sales in the last 12 months. The latest filing, on December 23, 2024, reports grant or award and shares withheld for taxes or exercise price at Biocryst Pharmaceuticals Inc (BCRX).

Filings
10
Companies
1
Bought on market
$642K
Sold on market
$62.1K

Companies where Anthony Doyle is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Biocryst Pharmaceuticals Inc logo
BCRX
Biocryst Pharmaceuticals Inc
Chief Financial Officer377,867$642K$62.1K$8.97$7.22-20%Dec 23, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Anthony Doyle with

Other insiders at the same companies

Questions about Anthony Doyle

What is Anthony Doyle's role at Biocryst Pharmaceuticals Inc?
Anthony Doyle reports to the SEC as chief Financial Officer at Biocryst Pharmaceuticals Inc (BCRX), according to the latest filing on December 23, 2024.
How many shares does Anthony Doyle own?
After the latest filing that states it, Anthony Doyle directly owned 377,867 shares of Biocryst Pharmaceuticals Inc (BCRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Anthony Doyle bought or sold stock recently?
The most recent open-market purchase was on May 14, 2024: bought 36,300 shares of Biocryst Pharmaceuticals Inc (BCRX) for $202K at an average of $5.57. The most recent open-market sale was on December 15, 2022: sold 5,700 shares of Biocryst Pharmaceuticals Inc (BCRX) for $62.1K at an average of $10.90.
How do I get alerts when Anthony Doyle files?
Follow Anthony Doyle on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Anthony Doyle (SEC CIK 0001808688). Totals count each trade once, skipping amendments whose original is on file, from Nov 24, 2021 on. View on SEC EDGAR · Get this as JSON